BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sloan S. Rabeprazole-based therapy in the management of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003;98:S49-55. [PMID: 12644031 DOI: 10.1016/s0002-9270(03)00015-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Moayyedi P, Santana J, Khan M, Preston C, Donnellan C; Cochrane Upper GI and Pancreatic Diseases Group. Medical treatments in the short term management of reflux oesophagitis. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd003244.pub3] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
2 Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007;CD001216. [PMID: 17253456 DOI: 10.1002/14651858] [Cited by in Crossref: 2625] [Cited by in F6Publishing: 769] [Article Influence: 175.0] [Reference Citation Analysis]
3 Sigterman KE, van Pinxteren B, Bonis PA, Lau J, Numans ME. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev. 2013;CD002095. [PMID: 23728637 DOI: 10.1002/14651858.cd002095.pub5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]